An abiotic fluorescent probe for the detection and quantification of carcinoembryonic antigen

Bioorg Chem. 2022 Feb:119:105490. doi: 10.1016/j.bioorg.2021.105490. Epub 2021 Nov 20.

Abstract

The reported methods mainly use biomolecules such as antibodies, enzymes, and aptamers for biomarker detection. However, applying an abiotic fluorescent probe to detect cancer biomarkers such as carcinoembryonic antigen (CEA) has not been reported. In this regard, we conceived an abiotic fluorescent probe BIQ-1 for the rapid yet straightforward detection of CEA. The bioinformatics tools and molecular docking techniques were used to develop the probe BIQ-1 for the selective detection and quantification of CEA in a buffer matrix resembling serum. The probe BIQ-1 exhibited a limit of detection of 0.2 ng/mL for CEA in a simple cuvette-based experiment. The BIQ-1 did no show interference from the possible interfering components such as hemoglobin, intralipid, and human serum albumin (HSA) in concentrations several-fold higher (µg/mL) than CEA.

Keywords: Abiotic fluorescent probe; Bioinformatics; Biomarker; Biosensors; CEA; Cancer; Carcinoembryonic antigen; Detection; Molecular docking.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor* / blood
  • Carcinoembryonic Antigen* / blood
  • Computational Biology
  • Dose-Response Relationship, Drug
  • Fluorescent Dyes* / chemical synthesis
  • Fluorescent Dyes* / chemistry
  • Humans
  • Molecular Docking Simulation
  • Molecular Structure
  • Structure-Activity Relationship

Substances

  • Biomarkers, Tumor
  • Carcinoembryonic Antigen
  • Fluorescent Dyes
  • BIQ-1